SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III Study

​ Conditions: Non-squamous Non-small Cell Lung Cancer

Interventions: Drug: SHR-A2009 + bevacizumab; Drug: Sacituzumab Tirumotecan

Sponsors: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Not yet recruiting Conditions: Non-squamous Non-small Cell Lung Cancer
Interventions: Drug: SHR-A2009 + bevacizumab; Drug: Sacituzumab Tirumotecan
Sponsors: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Not yet recruiting